The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Symetra plans to expand group life business

January 11, 2011 1:45 pm | by The Associated Press | News | Comments

Symetra Life Insurance Co. said Tuesday it plans to expand group life insurance business and has hired a former Aetna executive to head the segment.Symetra, which provides medical stop-loss coverage, plans to leverage its relationship with employee benefits brokers to ramp up its group life and...

Kinesiology joins College of Nursing & Health Innovation

January 11, 2011 12:34 pm | by Arizona State University | News | Comments

Kinesiology traces its origins to 1896 when the Tempe Normal College added Physical Education to its academic more


Countdown to Paris and ESC Congress 2011

January 11, 2011 11:39 am | by EurekAlert | News | Comments

(European Society of Cardiology) With its spotlight theme of ?Controversial Issues in Cardiology?, the 2011 edition of the European Society of Cardiology Congress promises lively discussions and ground-breaking debate. The ESC Congress is well established as the world's premier...


IPI granted $340K for neonatal adhesives

January 11, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The nonprofit Institute for Pediatric Innovation Inc. (IPI) in Cambridge, working with Brigham and Women's Hospital and Children's Mercy Hospitals and Clinics, has received a $340,000 grant from Philips Healthcare to develop an adhesive medical device to be used in neonatal intensive care units.

Russian Hospitals Digitize Medical Information, Improve Access to Patient Data With IBM Technology

January 11, 2011 11:38 am | by IBM | News | Comments

IBM announced today that multiple hospitals throughout Russia have switched from paper-based medical systems to a new solution from IBM and Complex Medical Information Systems (C-MIS) to provide fast electronic medical record exchange and unified access to many types of healthcare data,...

St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement

January 11, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

ROSLYN, N.Y., Jan. 11, 2011 /- Newell Robinson, M.D., Chairman of the Department of Cardiothoracic & Vascular Surgery; George Petrossian, M.D., Director of Interventional Cardiovascular Procedures; Andrew Berke, M.D., interventional cardiologist; and Roberto Colangelo, M.D.,...


Amarin Announces Successful Completion of Offering of American Depositary Shares

January 11, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

MYSTIC, Conn. and DUBLIN, Jan. 11, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that it has completed its previously announced underwritten public offering of American...


Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research

January 11, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Jan. 11, 2011 /- Syndax, a clinical-stage epigenetics oncology company, announced publication of data of entinostat combined with the demethylating agent Vidaza® (azacitidine) showing effect in reducing tumor burden in differentiated tumor cells in animal tumor models...


New molecular imaging technologies for detecting cellular processes

January 11, 2011 11:35 am | by EurekAlert | News | Comments

(Carlos III University of Madrid) A group of researchers at Universidad Carlos III de Madrid have designed and developed a biomedical scanner that detects cellular processes at the molecular level and indicates malfunctioning of an organ before said malfunction can produce an anatomical change.


No More Déjà Vu — Improving Your Practice in 2011

January 11, 2011 11:34 am | by Diagnostic Imaging | News | Comments

We must accept: 1) the assertion that market and political forces are designed to lower our incomes and profits; and 2) it is our responsibility to innovate and act proactively to manage change. With this acceptance we can actually improve our income and profits rather than sitting on the...


Town Hall Discussion With the Director of CDRH and Other Senior Center Management, March 10, 2011

January 11, 2011 11:31 am | by U.S. Food & Drug Administration | News | Comments

The objective of this Town Hall meeting is to engage in a dialogue about issues that are of importance to the public.


Orthofix promotes CFO Vaters to new role of COO

January 11, 2011 9:45 am | by The Associated Press | News | Comments

Medical device maker Orthofix International NV said Tuesday it promoted Robert Vaters to chief operating officer.Vaters had been chief financial officer since September 2008, when he joined the company.Orthofix appointed Brian McCollum as its interim CFO. He is the company's senior vice president...

RF Technologies® Announces Distributor Agreement With Universal Hospital Services

January 11, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

BROOKFIELD, Wis., Jan. 11, 2011 /- RF Technologies®, a leading provider of radio frequency identification monitoring systems and healthcare security solutions, has announced a distributor agreement with Universal Hospital Services, Inc. ("UHS"), a leading provider of medical...


Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences?

January 11, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, Jan. 11, 2011 /- Tonight's "Dan Rather Reports" examines the alarming health consequences resulting from the overuse of antibiotics. Every year, more than 90,000 Americans die from "superbugs" that antibiotics cannot treat; these antibiotic-resistant infections, caused directly by...


BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers

January 11, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

NOVATO, Calif., Jan. 11, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced the initiation of a Phase 1/2 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor in development for the treatment of genetically-defined cancers.   "PARP inihibtors have been...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.